Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease

Male Endocrinology, Diabetes and Metabolism Coronary Artery Disease Kaplan-Meier Estimate Risk Assessment 03 medical and health sciences 0302 clinical medicine Humans Registries Renal Insufficiency Original Investigation Aged Hypolipidemic Agents Proportional Hazards Models Randomized Controlled Trials as Topic Retrospective Studies Metabolic Syndrome Chi-Square Distribution Age Factors Middle Aged Prognosis 3. Good health Multivariate Analysis Female Bezafibrate Cardiology and Cardiovascular Medicine
DOI: 10.1186/s12933-016-0466-6 Publication Date: 2016-10-28T10:16:38Z
ABSTRACT
Data regarding long-term association of metabolic syndrome (MetS) with adverse outcomes are conflicting. We aim to determine the independent MetS (based on its different definitions) 20 year all-cause mortality among patients stable coronary artery disease (CAD).Our study comprised 15,524 who were enrolled in Bezafibrate Infarction Prevention registry between February 1, 1990, and October 31, 1992, subsequently followed-up for through December 2014. was defined according two definitions: The International Diabetes Federation (IDF); National Cholesterol Education Program-Third Adult Treatment Panel (NCEP).According IDF criteria 2122 (14%) had MetS, whereas NCEP definition 7446 (48%) MetS. Kaplan-Meier survival analysis showed that significantly higher by both (67 vs. 61%; log rank-p < 0.001) as well 54%; criteria. Multivariate adjusted risk 17% greater [Hazard Ratio (HR) 1.17; 95% Confidence Interval (CI) 1.07-1.28] 21% (HR 1.21; CI 1.13-1.29) using definition. Subgroup demonstrated increased associated consistent most clinical subgroups excepted renal failure (p value interaction 0.05).Metabolic is independently an 20-year CAD. This when either or definitions used. Trial registration retrospective registered.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (55)
CITATIONS (43)